Results 271 to 280 of about 119,167 (297)

Glucagon-like Peptide-1 Receptor-based Therapeutics for Metabolic Liver Disease

Endocrine Reviews, 2023
Daniel J Drucker
exaly  

Glucagon Like Peptide 2 (GLP-2)

2018
Georgios K. Dimitriadis, Alexander D. Miras   +1 more
openaire   +1 more source

Glucagon-like peptide-2: Divergent signaling pathways1

Journal of Surgical Research, 2004
Flavio G. Rocha, K. Robert Shen, Jasleen Jasleen, Ali Tavakkolizadeh, Michael J. Zinner, Edward E. Whang, Stanley W. Ashley   +6 more
openaire   +1 more source

Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes: a parallel-group study

Lancet, The, 2002
Sten Madsbad, Jens J Holst Dmsci
exaly  

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

Lancet, The, 2006
Daniel J Drucker, Michael A Nauck
exaly  

Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2 diabetes: a systematic review and meta-analysis

Lancet, The, 2014
Bernard Zinman Cm, Ravi Retnakaran, Caroline K Kramer   +2 more
exaly  

Antidiabetogenic Effect of Glucagon-like Peptide-1 (7–36)amide in Normal Subjects and Patients with Diabetes Mellitus

New England Journal of Medicine, 1992
Jens J Holst Dmsci, Bo Ahrén
exaly  

Glucagon-Like Peptide-2

1994
openaire   +1 more source

Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1

Cell Metabolism, 2018
Daniel J Drucker
exaly  

Glucagon-Like Peptide-2

2016
openaire   +1 more source